Hespecta Vaccination in HPV+ Tumors or Malignant Lesions

Clinical trial NCT02821494 · COMPLETED

Trial details

NCT number: NCT02821494
Sponsor: Leiden University
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Tumors or Premalignant Lesions

Start date: 2015-03-01
Primary completion: 2020-03-01
Enrollment: 25

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.